ResultsIQ › Latest results › Medi Assist Healthcare Services Limited
Medi Assist Healthcare Services Limited Q2 FY27 results deck summary
NSE: MEDIASSIST · BSE: 544088
Results deck of 1 Nov 2026, summarised by AI from the filing.
Q2 FY27 EBITDA margin 20.4%, up 331 bps YoY, as Paramount integration completed and platform revenue grew 112.6%.
Key takeaways
- Q2 margin Q2 FY27 EBITDA margin 20.4%, up 331 bps YoY, with EBITDA ₹49.2 cr up 23.9% and reported PAT ₹21.6 cr up 167.5%.
- Retention guidance Management expects group retention rates to normalize within 3 to 4 quarters as the churn tail runs about 2-3 quarters.
- Margin recovery EBITDA margin recovered 330 bps in four quarters from the 22.1% pre-Paramount level, with integration costs completed in Q2 FY27.
- Platform growth SaaS and licence revenue grew 112.6% YoY in Q2 FY27, with ₹9,648 cr of premiums on the platform in H1 FY27, up 24.8%.
- Retail decline Retail TPA revenue fell 1.8% YoY and retail premiums managed fell 8.5% YoY in H1 FY27.
Medi Assist Healthcare Services Limited Q2 FY27 results
As filed: Revenue ₹242 cr (+4% year on year), EBITDA ₹49.2 cr (+23% year on year), PAT ₹21.6 cr (+170% year on year), EBITDA margin 20.4% (+322 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹237 cr (+24% year on year), EBITDA ₹48.0 cr (+12% year on year), PAT ₹27.6 cr (+20% year on year), EBITDA margin 20.3% (−221 bps). Score 54 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 221 bps year on year. Other income 30% of PBT. Profit fell 49% from last quarter. Revenue rose ₹45.5 cr on a year ago, more than the ₹23.0 cr it added the year before. Share price after the results: −7.8% in 30 days (Nifty 500: −2.3%).
- Q4 FY26: Revenue ₹242 cr (+28% year on year), EBITDA ₹48.3 cr (+21% year on year), PAT ₹54.5 cr (+148% year on year), EBITDA margin 19.9% (−123 bps). Score 78 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin fell 123 bps year on year. Tax rate -95%. Revenue rose ₹53.0 cr on a year ago, more than the ₹22.0 cr it added the year before. Share price after the results: −7.2% in 30 days (Nifty 500: −4.1%).
- Q3 FY26: Revenue ₹240 cr (+29% year on year), EBITDA ₹44.6 cr (+14% year on year), PAT ₹4.1 cr (−16% year on year), EBITDA margin 18.6% (−235 bps). Score 44 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was above it; profit before exceptional items growth was below it. EBITDA margin fell 235 bps year on year. Other income 89% of PBT. Tax rate 51%. Consolidated profit -86% but standalone +196%. Revenue rose ₹53.7 cr on a year ago, more than the ₹20.0 cr it added the year before. Share price after the results: −19.9% in 28 days (Nifty 500: −4.1%).
- Q2 FY26: Revenue ₹233 cr (+29% year on year), EBITDA ₹40.0 cr (+3% year on year), PAT ₹8.0 cr (−62% year on year), EBITDA margin 17.2% (−438 bps). Score 29 of 100, Below trend. EBITDA margin fell 438 bps year on year. Tax rate 38%. Consolidated profit -62% but standalone +80%. Not enough history for a trend yet: scored on growth alone. Profit fell 65% from last quarter. Share price after the results: −15.6% in 30 days (Nifty 500: +0.7%).
- Q1 FY26: Revenue ₹191 cr (+14% year on year), EBITDA ₹43.0 cr (+19% year on year), PAT ₹23.0 cr (+21% year on year), EBITDA margin 22.5% (+108 bps). Score 57 of 100, In line with trend. EBITDA margin rose 108 bps year on year. Consolidated profit +21% but standalone -11%. Not enough history for a trend yet: scored on growth alone. Share price after the results: −4.8% in 29 days (Nifty 500: +0.6%).
- Q4 FY25: Revenue ₹189 cr (+13% year on year), EBITDA ₹40.0 cr (+8% year on year), PAT ₹22.0 cr (−15% year on year), EBITDA margin 21.2% (−99 bps). Score 32 of 100, Below trend. EBITDA margin fell 99 bps year on year. Other income 27% of PBT. Not enough history for a trend yet: scored on growth alone. Profit fell 27% from last quarter. Share price after the results: −0.3% in 29 days (Nifty 500: +0.5%).
- Q3 FY25: Revenue ₹186 cr (+12% year on year), EBITDA ₹39.0 cr (+15% year on year), PAT ₹30.0 cr (+43% year on year), EBITDA margin 21.0% (+49 bps). Score 54 of 100, In line with trend. EBITDA margin rose 49 bps year on year. Tax rate -11%. Consolidated profit +43% but standalone -20%. Not enough history for a trend yet: scored on growth alone.
Past price moves after results do not indicate future moves. Not a recommendation.
Medi Assist Healthcare Services Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (2 Nov 2026), Results deck (1 Nov 2026)
- Q1 FY27: Earnings call (10 Aug 2026), Results deck (9 Aug 2026)
- Q4 FY26: Earnings call (11 May 2026), Results deck (11 May 2026)
- Q3 FY26: Earnings call (9 Feb 2026), Results deck (9 Feb 2026)
- Q2 FY26: Earnings call (5 Nov 2025), Results deck (5 Nov 2025)
- Q1 FY26: Earnings call (7 Aug 2025), Results deck (7 Aug 2025)
- Q4 FY25: Earnings call (15 May 2025), Results deck (15 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.